NP Thyroid costs more than generic synthetic thyroid medications primarily because it’s derived from animal tissue, which makes it more complex and expensive to produce, and because its regulatory status as an unapproved drug creates unique market dynamics. Without insurance, a 100-tablet supply of NP Thyroid 30 mg runs about $81, and prices climb with higher doses. By comparison, generic levothyroxine often costs under $20 for a comparable monthly supply.
Animal-Sourced Ingredients Cost More to Produce
NP Thyroid is a natural desiccated thyroid (NDT) medication made from pig thyroid glands. Unlike synthetic thyroid drugs, which are manufactured from standardized chemical compounds, NP Thyroid requires sourcing pharmaceutical-grade porcine tissue, processing it to precise hormone concentrations, and testing each batch to confirm consistent levels of both T4 and T3 hormones. That biological supply chain is inherently more expensive and less predictable than synthesizing a single molecule in a lab.
The raw material comes from pork processing facilities, and the supply depends on the livestock industry. Fluctuations in pork production, changes in slaughterhouse operations, and the cost of meeting pharmaceutical-grade purity standards all feed into the final price. Synthetic levothyroxine, by contrast, benefits from a straightforward manufacturing process with multiple generic manufacturers competing on price.
FDA Classification Creates a Complicated Market
The FDA does not approve animal-derived thyroid medications like NP Thyroid. The agency has stated that “due to their complex biological origin, these medications contain many compounds that are uncharacterized for safety and effectiveness.” This unapproved status has several downstream effects on cost.
Without FDA approval, NP Thyroid exists in a regulatory gray area. The FDA applies a “risk-based enforcement approach” to these products, meaning it can take action against manufacturers not meeting quality standards. This creates pressure on Acella Pharmaceuticals (NP Thyroid’s manufacturer) to invest heavily in quality control and testing, costs that get passed to consumers. The FDA has also noted that tablets from the same manufacturing batch may not always deliver consistent hormone levels, which means manufacturers must do extensive lot-by-lot testing to minimize variability.
Additionally, because these products aren’t FDA-approved, they can’t be compounded by pharmacies as an alternative. The FDA classifies them as biological products under the Public Health Service Act, which blocks the compounding route that sometimes provides cheaper alternatives for other medications.
Recalls Have Tightened Supply and Raised Costs
In May 2020, Acella Pharmaceuticals issued a voluntary nationwide recall of 13 lots of NP Thyroid across its 30 mg, 60 mg, and 90 mg strengths. The reason: testing found the tablets were “superpotent,” containing up to 115% of the labeled amount of T3 (the more active thyroid hormone). Too much T3 can cause rapid heartbeat, anxiety, and other serious effects.
Recalls like this pull large quantities of medication off pharmacy shelves, shrinking the available supply while demand stays constant. They also force the manufacturer to absorb the cost of destroyed inventory, additional testing protocols, and regulatory remediation. Those expenses ultimately show up in the product’s price. For patients, recalls also mean periods of scarcity where pharmacies may charge more for whatever stock remains, or patients are forced onto pricier alternatives.
How NP Thyroid Compares to Other Options
NP Thyroid was originally positioned as a more affordable alternative to Armour Thyroid, the best-known NDT brand. And it still is cheaper: Armour Thyroid 120 mg runs about $2.19 per tablet ($219 for 100 tablets), while NP Thyroid 30 mg costs roughly $0.81 per tablet ($81 for 100 tablets). But dose-for-dose comparisons at equivalent strengths narrow that gap, and both NDT products cost significantly more than generic levothyroxine.
The price difference between NDT products and synthetic generics comes down to competition. Generic levothyroxine has numerous manufacturers competing for market share, which drives prices down. The NDT market has far fewer players. NP Thyroid and Armour Thyroid are the two main options, and with limited competition, there’s less pressure to lower prices.
Insurance Coverage Varies Widely
Whether your insurance covers NP Thyroid depends heavily on your specific plan. Some insurers place it at favorable tiers. Cigna’s 2025 prescription drug list for one plan in Tennessee, for example, lists all NP Thyroid strengths at Tier 1, the lowest cost-sharing level alongside generics. But other plans may exclude it entirely. Some insurers specifically exclude medications that aren’t FDA-approved, which directly impacts NDT products.
If your plan doesn’t cover NP Thyroid or places it on a high tier, the out-of-pocket cost can feel steep compared to what you’d pay for a covered generic. This inconsistency in coverage is one of the biggest reasons patients experience sticker shock: switching plans or pharmacies can dramatically change what you owe.
Ways to Lower Your Cost
Acella Pharmaceuticals offers a direct purchasing option through Glendale Pharmacy, where a 30-day supply costs as little as $27 and a 90-day supply runs about $65, with free standard shipping to select states. Glendale Pharmacy also accepts insurance in some states, which could reduce the price further. Your prescriber would need to send the prescription directly to that pharmacy.
If you’re paying cash at a retail pharmacy, prices can vary substantially from one location to another. Discount programs like GoodRx sometimes offer lower negotiated rates. It’s also worth asking your prescriber whether your insurance would cover a different NDT product at a lower tier, since formulary placement differs between brands and plans.